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A HUMAN CULTURE MODEL OF THE OUTER BLOOD-RETINAL BARRIER IN AGE-RELATED
MACULAR DEGENERATION. Veena S. Rao, Shaomin Peng, Ron A. Adelman, and Lawrence J.
Rizzolo. Section of Surgery, Department of Ophthalmology, Yale School of Medicine, New Haven, CT.

In age-related macular degeneration (AMD), the outer blood-retinal barrier is exposed to various pathologic
factors which can result in visual detriment. Two such stimuli include serum, as may be seen in neovascular
AMD, and proinflammatory cytokines, which may be seen in neovascular and non-neovascular AMD. To
examine effects of serum and cytokines in disease, we adapted an outer blood-retinal barrier culture model
using human fetal retinal pigment epithelium (hfRPE) to investigate effects on tight junctions. Specifically,
we focused on the claudin family and occludin tight junction proteins. HfRPE was cultured on filters in
growth medium until quiescent monolayers were formed; cells were then either maintained in growth
medium or switched to a serum-free medium. To study serum effects, serum-free medium maintained cells
were exposed to serum in apical, basal, or both media chambers. To study cytokine effects, growth medium
and serum-free medium cells were exposed to TNF-α (10ng/mL), IL-1β (10ng/mL), or INF-γ (5ng/mL) in
both media chambers for 48 hours. Effects were measured at the functional level (transepithelial electrical
resistance; ion selectivity), mRNA level (RT-PCR, quantitative, real-time RT-PCR), and protein level
(immunoblotting; immunofluorescence). Claudin 19 was the predominant claudin with mRNA expression
>20× that of any other claudin and exhibited protein expression in every cell. siRNA knockdown of
claudin 19 resulted in functionally deficient tight junctions. Apical, corresponding to subretinal, serum
increased TER 2-3× and altered ion selectivity; basal serum had no effect. Apical serum effects were
accompanied by increases in occludin protein levels. TNF-α decreased TER and altered ion selectivity in
both media conditions; IL-1β and INF- γ had little or inconsistent effects. TNF-α exposure lowered claudin
19 but raised claudin 2 and occludin levels. Preventing the increase of claudin 2 with an siRNA did not
alter the effect of TNF-α; this suggests TNF-α decreased TER by a different mechanism. This culture
model of the outer blood-retinal barrier in AMD suggests claudin 19 is essential for the formation of
functional tight junctions. Subretinal serum results in a tightened outer blood-retinal barrier, which may be
mediated by occludin; this tightening may help limit the spread of disease. Inflammatory cytokines,
particularly TNF-α, appear to alter tight junction function and properties which may potentiate
inflammatory diseases such as AMD.
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1
Introduction

Age-related macular degeneration (AMD) is the most common cause of blindness in
people 50 years or older in the Western world (1). Within the United States alone, more
than 8 million people are affected. AMD is characterized by a progressive loss of central
vision; this vision loss is particularly devastating because it involves the macula, which is
responsible for high-resolution vision (2). Clinically, AMD is classified as either: 1)
neovascular, the more devastating form of disease in which abnormal, leaky capillaries
develop posterior to the retina or 2) non-neovascular, which involves degeneration of
cells in the macula. Although AMD is of major public health importance, its pathogenesis
is not well understood. In this study, we seek to develop and adapt a human culture model
that will facilitate further study of AMD. In particular we concentrate on the tight
junctions of the outer blood-retinal barrier, which likely play a major role in this disease.
Further, we use this model to examine two pathogenic factors thought to be important in
AMD: 1) serum, as might be involved in neovascular AMD and 2) proinflammatory
cytokines, which likely are involved in both neovascular and non-neovascular AMD.

Disruption of the normal architecture of the eye is a key feature of AMD. In a healthy
eye, the retina and its photoreceptors lie directly anterior to the retinal pigment epithelium
(RPE) (1,3). Posterior to the RPE lies Bruch’s membrane, a semipermeable barrier
between the RPE and choroid. The choroid in turn contains blood vessels and serves as a
vascular layer supplying blood to the outer retina. The outer blood-retinal barrier, which
the RPE helps form, is an integral segment of this system (4); this barrier maintains
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normal photoreceptor function by regulating the components of the subretinal space,
which lies between the retinal photoreceptors and the RPE. In neovascular AMD, the
blood-retinal barrier is violated by choroidal capillaries, which can grow into the
subretinal space. The breakdown of this barrier may result in edema; this can be
visualized clinically through fluorescein angiography (2).

The outer blood-retinal barrier, like other tissue barriers, is comprised of two major
entities: 1) membrane proteins which regulate transcellular movement of solutes and 2)
tight junctions, also known as zonula occludens, which control the paracellular pathway
of diffusion (please see Figure 1) (5). Tight junctions exist at the apical and lateral
surfaces of epithelial cells; they form a selectively permeable barrier between the apical
and basolateral spaces of an epithelial cell layer (6,7). When examined in cross-section
by transmission electron microscopy, tight junctions are visualized as areas of repeated
touching of lateral cell membranes. The points at which cell membranes ‘touch’ consist
of many cross-linked protein strands. When viewed enface by freeze-fracture electron
microscopy, the ‘touching’ points appear as a series of parallel, anastomosing strands
which reach from cell to adjoining cell within the plane of the plasma membrane (8).
Tight junctions wrap circumferentially around epithelial cells, forming a distinct barrier
(9). The stringency of this barrier of tight junctions is in part determined by the number
and nature of these protein strands (6),(10).
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Figure 1: Paracellular and transcellular transport pathways of the RPE. The RPE
regulates the subretinal space through both paracellular and transcellular pathways, as
illustrated on the left. The paracellular pathway is a non-vectorial pathway while the
transcellular pathway is vector-dependent using active transport. On the right, an
enlargement of the lateral cell membranes is shown, illustrating the tight junctions that lie
between cells. Figure from Rizzolo 2010 (11).

The barrier properties of tight junctions are in large part determined by the profile of
claudin tight junction proteins expressed. To satisfy the needs of different epithelia,
different cells and tissues have varying claudin expression profiles (12). The claudin
family of tight junction proteins, first discovered in 1998, is a group of at least 24
transmembrane proteins that are integral to tight junction formation (13),(14). Studies
suggest claudins are the most important proteins for determining the barrier properties of
tight junctions (12,15,16). For instance, when individual claudins are expressed in
Madin-Darby canine kidney (MDCK) epithelial cells in culture, resistance of the barrier
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is altered. Every claudin appears to have its own specific selectivity and permeability
profile. For example, claudin 2 and claudin 10 both increase the permeability of tight
junctions to cations (17). Claudin 19 decreases the permeability of chloride ions. In the
tight junctions of the human eye, claudin 19 appears to have a particularly important role
since patients with mutations in this gene exhibit severe ocular deficits (18). In addition
to myopia, nystagmus, and macular colobomata, these patients also showed renal deficits,
highlighting the importance of this gene to multiple physiological functions. The
presence of ocular and renal defects seen in these claudin 19-deficient patients follows
intuitively as claudin 19, unlike the ubiquitous claudins 1 and 3, is only found in the eye
and kidney. It is possible that the ocular deficits seen in these patients are the result of
defects in the formation of the blood-retinal barrier during development. It is also
possible that claudin 19 exhibits other functions critical to normal ocular function.

In addition to the claudins, occludin is a transmembrane protein that likely also works to
regulate tight junction permeability (19-22). Tight junctions exhibit the ability to respond
to various stimuli; this capability is likely mediated by the plastic nature of various tight
junctional proteins. Occludin was the first transmembrane protein to be discovered and is
thought to be highly dynamic (23,24). This protein’s short 1.5 hour half-life points to its
potential role in adjusting the permeability of tight junctions on a rapid time-scale to
physiologic stimuli.

As described above, the outer blood-retinal barrier is comprised of RPE cells. These cells
help maintain a proper environment within the subretinal space to allow normal
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photoreceptor function. RPE cells are pigmented with melanin and lie in a monolayer
between the neural retina and the choroid (please see Figure 2) (5). In addition to
regulating the transport of nutrients, solutes, and water between the subretinal space and
the blood, RPE absorbs light transmitted to the retina to prevent reflection of light back
into the photoreceptor layer, phagocytoses photoreceptor byproducts, and secretes
various factors for the maintenance of ocular function (25). The RPE also plays a key role
in the visual cycle: photoreceptors, which are not capable of isomerizing all-trans-retinal
back to 11-cis-retinal, transport retinal to the RPE for this reisomerization to facilitate
photoreceptor function.

Figure 2: Normal retinal architecture. Seen here is a cross-sectional depiction of the
normal posterior segment architecture, including the neural retina, the retinal pigment
epithelium, Bruch’s membrane, and the choroid. Shown also is the pathway of light: 1)
entering the retina; 2) passing through the sensory retina; 3) being detected by the
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photoreceptor layer (rods and cones); and 4) subsequently being absorbed by the RPE to
prevent reflection back into the photoreceptor layer. Figure adapted from Kolb 2007 (26).

Due to its myriad functions which help maintain visual function, RPE is a desirable
candidate for study. Differentiated cells such as RPE often lose their properties when
maintained for multiple passages in culture (27); because of this, primary and secondary
cultures of RPE have been targeted for their ability to preserve cell function in vitro (2831). Many of these cultures, however, do not develop appropriate tight junction function.
ARPE19 is a spontaneously derived human RPE cell line that exhibits tight junction
function and normal-appearing morphology. However, the transepithelial electrical
resistance reported for this cell line is 90 Ω×cm2 while that of human RPE in vivo is
estimated at 206 Ω×cm2 (32).

Data also show that the characteristics and protein

composition of ARPE19 differ depending upon culture conditions (33,34). Human fetal
RPE (hfRPE) has hence been proposed as a preferable model. Previous work reflects
three hfRPE culture models which appear to exhibit more developed tight junctions than
ARPE19. Maminishkis and colleagues cultured a model derived from 16-18 week
gestation fetuses in a 5% serum-containing MEM-α modified medium; the model showed
an average TER of 501 Ω×cm2 (35). Another model derived from 21 week fetuses and
cultured in 1% serum-containing calcium-free MEM (Eagle) medium showed an average
TER of 834 Ω×cm2 (36). Gamm and colleagues developed a model from 10-16 week
gestation fetuses in a culture medium that was entirely serum-free and with a TER of
approximately 500 Ω×cm2 (37). All three models exhibited normal-appearing
morphology and physiological function. Considering the variable TER of these models,
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however, it seems likely that their structural composition varies. The similarity of these
models to native RPE has yet to be established. Although hfRPE and its barrier function,
including tight junction characteristics, has not been fully characterized, it appears a
promising model for the outer blood-retinal barrier and its relationship to various
diseases.

In neovascular AMD, leaky choroidal capillaries invading the subretinal space may
release blood within this normally tightly controlled area. In lower vertebrate models of
RPE, the composition of medium, including serum content, helps determine the
composition and tight junction permeability of the RPE (38-41). Particularly, when serum
was present on the apical, corresponding to the subretinal, side of a chicken RPE model
tight junctions were leakier (40). This result would support a hypothesis that subretinal
serum, as might be seen in neovasular AMD, may help perpetuate edema through leaky
tight junctions. The increased permeability of RPE tight junctions could spread from cell
to cell leading to the gross lateral spread of edema (42). As with all animals, these models
may not be directly applicable to humans. Prior hfRPE studies as discussed above do,
however, point to a role of medium serum composition in determining the properties of
the RPE barrier (35-37).

AMD is currently thought to involve a low-grade inflammatory and/or immune
component (43-46). Clinically, drusen—extracellular debris which collect under the
RPE—have been identified as a risk factor for AMD development. Characterization of
drusen suggests a role for inflammation and auto-immune processes in AMD, particularly
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involvement of complement factor (47,48). Several studies have shown a strong
association between complement factor H polymorphisms and AMD (49-52). Further
study replicates these findings (46,53,54). As such, cytokines may be a critical
component in the development of this and similar ocular diseases. Prior work supports
such a role for proinflammatory cytokines (55-61). TNF-α, IL-1β, and IFN-γ have all
been implicated in the regulation of epithelial tight junctions in vivo and in vitro (62-65).
As further evidence of cytokine involvement, TNF-α inhibitors have been successfully
used to treat a variety of these diseases (66-68).

Inflammation during the AMD disease process may trigger inflammatory mediators
which injure the retina and the RPE blood-retinal barrier. Abe and colleagues show that
IL-1β altered tight junction proteins in the human RPE cell line ARPE-19 (34). When
TNF-α, IL-1β, and IFN-γ were all added to a hfRPE culture, the TER decreased and fluid
absorption from the apical to basal side of the model increased (35,36). This prior work
points to these particular cytokines as potentially important in the inflammatory response
causing blood-retinal barrier dysfunction in AMD and other inflammatory diseases.

Here, we seek to develop and adapt a human fetal RPE culture model of the outer bloodretinal barrier in order to better evaluate AMD. Following the evaluation of this culture
model, we will test the effects of two potential major pathogens in AMD. One branch of
the study will investigate the effects of serum on this outer blood-retinal barrier model in
order to examine neovascular AMD. The other branch of the study will evaluate the
potential role of proinflammatory cytokines in the pathogenesis of inflammatory ocular
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diseases, such as AMD. Portions of this study have been previously published (42). The
contributions of the individual authors are noted within the text of this thesis.
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Statement of purpose, specific hypothesis, and specific aims

The purpose of this study is to examine aspects of AMD in culture. In order to study
AMD, we sought to develop and adapt a consistent, appropriate in vitro model of the
outer blood-retinal barrier. Although culture models of the outer blood-retinal barrier
exist, as reviewed in the Introduction, these current models present some difficulties in
the study of AMD. The spontaneously transformed ARPE19 cell line, for example,
exhibits a TER substantially lower than that seen in native tissue. Two of the three
current hfRPE models (35,69), utilize serum. The use of serum may be problematic
because: 1) variabilities between different serum samples can create intrinsic variabilities
between models and 2) the study of neovascular AMD by adding serum or whole blood
to the model may be complicated as serum would be already present within the culture
media. Moreover, the paracellular pathway of current hfRPE models has not been
compared to native hfRPE so their appropriateness as culture models has not been
elucidated. For these reasons, we strive here to identify a culture model that can be used
to effectively model the outer blood-retinal barrier; this model will then be used to study
AMD in culture. We hypothesize it will be possible to develop such a model using hfRPE
and that its functions and characteristics will be similar to native hfRPE. Further, we feel
it will be possible to maintain this model without using serum in the culture medium. In
modeling AMD, it is most likely that 1) the addition of serum to the subretinal space, as
might be expected in neovascular AMD, will result in leakier tight junctions that will
perpetuate disease, as seen in studies of lower vertebrates and 2) the addition of
proinflammatory cytokines to the model, as is likely seen in inflammatory diseases such
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as AMD, will cause the tight junctions of the outer blood-retinal barrier to become
leakier, thus potentiating disease.

Specific Aims:
I will test the hypotheses that:
(1) an outer blood-retinal barrier model using hfRPE will have tight junction function
and composition that closely resembles that of native RPE
a. In order to assess the appropriateness of the culture model, native human
fetal RPE will be characterized to allow comparison
b. We will assess varying culture media and conditions to determine if there
is a most appropriate growth condition. A major tenet of this aim is to
assess if a serum-free model would be possible; this would eliminate
potential effects of serum variations on the model
(2) in neovascular AMD, modeled here by the addition of serum to the serum-free
culture model, serum will result in leakier tight junctions that may perpetuate
disease
(3) the addition of proinflammatory cytokines to the model in order to simulate AMD
will cause leakier tight junctions in the outer blood-retinal barrier, an effect which
may potentiate disease
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Methods

These methods are an elaboration of the methods published in Peng et al. 2010, of which
I am a coauthor.

Cell Culture

All research performed is in accordance with the tenets of the Yale School of Medicine
guidelines, the institutional review board of the National Institutes of Health, and the
Declaration of Helsinki. Primary cultures of human fetal RPE (hfRPE) cells were a
generous gift from the laboratory of Sheldon Miller (National Eye Institute, Bethesda,
MD). Once obtained in our lab, cells were trypsinized in 0.25% trypsin-EDTA for 10
minutes and then centrifuged for 10 minutes at 1500U/min. Cells were then resuspended
in growth medium with 15% fetal bovine serum (FBS, Atlanta Biologicals, Norcross
GA). Growth medium has a base of Minimum Essential Medium Eagle with αmodification (Sigma-Aldrich, St. Louis, MO) plus the following components: 5% heatinactivated FBS; 2% N1 supplement (Sigma-Aldrich); 1% glutamine-penicillinstreptomycin (Sigma-Aldrich), 1% nonessential amino acid solution (Sigma-Aldrich),
hydrocortisone (20 µg/L), taurine (250 mg/L), and triiodo-thyronin (0.013 µg/L)(35).
Clear cell culture inserts (Transwell, 12mm diameter inserts, 0.4µm pores, polyester
membranes; Corning Costar, Corning, NY) were prepared by coating with human
extracellular matrix (10 µg in 150 µL Hank’s Balanced Salt Solution per well; BD
Biosciences, Franklin Lakes, NJ) and treated in a fume hood with UV light for 2 hours.
Cells were then seeded at a density of 1.3x105 per well on the Transwell filter (see Figure
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3). The volume of medium in the apical chamber is 0.6 mL and that of the basal chamber
is 1.5 mL. All cell cultures were maintained in an incubator with temperature of 37°C
with 95%air/5%CO2.. Media was changed at 24 hours and was subsequently changed 3
times per week. Cells were used for experimentation only after their transepithelial
electrical resistance (TER, see below for methods) became stable, at approximately 4-5
weeks.

During experimentation, serum concentration and/or medium was altered as noted within
the Results. For serum-free medium experiments, cells were switched to serum-free
medium only after they reached a stable TER. The serum-free medium has a base of 70%
Dulbecco’s Modified Eagle Medium with 4.5 g/L D-glucose (Invitrogen), 30% F12
nutrient mixture containing L-glutamine (Invitrogen), 1% antibiotic-antimycotic solution
(Invitrogen), and 2% B27 (Invitrogen) (37). Once transferred to serum-free medium, cell
cultures showed an additional decrease in TER for approximately 4 weeks. Again, cells
were only used for experimentation after their TER had stabilized.

To test the effects of serum on the model, 5% FBS was added to the apical chamber,
basal chamber, or both chambers of a serum-free culture model for up to 15 days.

To test the effects of proinflammatory cytokines, two different media conditions were
utilized: 1) serum-free media and 2) growth medium with 0.5% serum. Growth medium
with 0.5% serum was utilized to minimize potential effects of serum; we had found
previously that this lowered serum concentration showed no effects on cell morphology
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or barrier function (unpublished data). TNF-α (10 ng/mL), IL-1β (10 ng/mL), or IFN-γ (5
ng/mL) was added to the both medium chambers in either the growth medium model or
serum-free model for 48 hours.

Figure 3: Transwell filter on which hfRPE cells are grown.

Assessment of Transepithelial Electrical Resistance and Ion Selectivity

The TER of cell cultures was measured using endohm electrodes (World Precision
Instruments, Sarasota, FL) using the manufacturer’s protocol. Briefly, the electrode was
calibrated to zero. Next, each cell culture cup was transferred into the endohm electrode
chamber and a single resistance measurement was recorded for each sample.
Measurements were made at 33°C—and not ambient temperature—to avoid the phase
transition that occurs in tight junctions at ambient temperature and because this
temperature was readily maintained. All measurements were made in culture medium
(either growth medium or serum-free medium).

To examine ion selectivity, we measured the TER of samples in various salt solutions to
form as estimate of the ion selectivity for different cations. Conductance was calculated
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from TER measurements (conductance = 1/resistance). Using Eisenmen’s method for the
examination of ion channel selectivity, we prepared buffers containing 2mM CaCl2, 1mM
MgCl2, 2mM BaCL2, 10mM glucose, 10mM HEPES, pH 7.4, and either 150mM NaCl or
KCl (70,71). The osmolarity of the buffer was measured to be between 310-315 mOsm to
mach the osmolarity of the culture medium. Cell culture samples were incubated with
each respective buffer for one hour to allow resistance to stabilize; TER was then
measured for reach sample. Cells were then incubated with culture medium for one hour
to ensure any changes in resistance was reversible and that cells were viable.

Cell culture, TER measurement, and ion selectivity measurements were primarily
performed by Shaomin Peng.

Paracellular flux of methylpolyethylene glycol (mPEG)

Cells were incubated with culture medium containing 10mM NH4Cl for 30 minutes
before mPEG (either average molecular weight 550 or 350; MP Biomedicals, LLC Solon,
Ohio) was added to either the apical, basal, or both media chambers to a final
concentration of 50 µg/mL. Samples were incubated for 1.5 hours at 37°C with 5% CO2.
Following incubation, medium from the chamber opposite to the chamber mPEG was
added was collected. A rabbit monoclonal PEG ELISA Kit (Epitomics, Inc, Burlingame,
CA) was used to measure mPEG concentration using the manufacturer’s protocol.

Paracellular flux of mPEG was performed by Shaomin Peng.
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RNA Isolation and Production of cDNA

Total RNA was extracted from samples using the RNeasy Plus Mini Kit (Quiagen,
Valencia, CA). Cell culture samples were harvested by removing Transwell filters from
the culture plate using a sterile blade. RNA isolation was then performed according to the
manufacturer’s protocol. RNA concentration was assessed by spectrophotometry and 2
µg of RNA was reverse transcribed into cDNA using the Quantitect Reverse
Transcriptase Kit (Qiagen, Valencia, CA).

RNA isolation and production of cDNA was performed by Veena S. Rao.

Reverse-Transcriptase-Polymerase Chain Reaction RT-PCR

RT-PCR amplification was performed using 0.1 µg of RNA and SuperScript® One-Step
RT-PCR with Platinum Taq (Invitrogen, Carlsbad, CA). The amplification reaction was
performed for 35 cycles with the C1000 Thermal Cycler (BioRad). Primers used are
shown in Table 1. PCR products were visualized on a 1.5% agarose gel stained with
ethidium bromide (Molecular Probes Inc, Eugene, OR) and imaged using a Molecular
Imager ChemiDoc XRS System (BioRad, Hercules, CA). Human kidney total RNA
(Biochain Institute Inc, Hayward, CA) was used as a positive control for claudin 10.

RT-PCR was performed by Veena S. Rao.
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Quantitative reverse transcriptase polymerase chain reaction (qRT-PCR)

qRT-PCR was performed using iQ SYBR Green SuperMix (BioRad, Hercules, CA) and
the

Bio-Rad

CFX96

thermal

cycler

following

the

manufacturer’s

protocol.

Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as a control to
normalize data. Each experiment was performed in triplicate with 2 repeats. Relative
expression of mRNA was calculated using the established 2-∆∆CT method (72); a twofold
change in expression was considered biologically significant. All data were normalized to
GAPDH and mRNA expression was compared to either claudin 19 mRNA expression or
to the control sample’s mRNA expression as appropriate (noted in Results).

Primer efficiency was determined for each primer. Serial 1:4 dilutions of cDNA were
made for a set of 4 total dilutions. Real-time RT-PCR was then performed with each
primer pair; PCR amplification efficiency of each primer pair was calculated by
constructing a standard curve using the C(t) value for each point of the dilution series
using BioRad CFX software (Bio-Rad, Hercules, CA). Efficiency was calculated using
this software following the equation: efficiency= (10(-1/slope)-1) × 100%. All primers used
had efficiency of ≥95%, except for claudin 10 and 15 primers whose results were
corrected for their lower efficiencies (88% and 87%, respectively) by multiplying C(t)
values by ln(2)/ln(1.88) or ln(2)/ln(1.87).

Quantitative real-time RT-PCR and primer efficiency determination were performed by
Veena S. Rao.
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Protein Electrophoresis and Immunoblotting

Cell culture samples were solubilized using 200 µL of 25mM Tris buffer, pH 8.0 with 2%
sodium dodecyl sulfate and 10 µL/mL Protease Inhibitor Cocktail (Sigma-Aldrich).
Samples were then centrifuged to remove melanin. Immunoblotting samples were then
prepared with the addition of EDTA to a final concentration of 5 mM in 50 µL of 5×
loading buffer. All samples were incubated for 10 minutes at 37°C followed by 5 minutes
in a boiling water bath. Protein concentration was determined using the Micro BCA
protein assay kit (Pierce, Rockford, IL) using manufacturer’s instructions; equal protein
amounts were run on a sodium dodecyl sulfate- polyacrylamide gel for subsequent
immunoblotting. α-tubulin was used as a control. Primary antibodies used are as follows:
rabbit polyclonal anti-claudin-1; rabbit polyclonal anti-claudin-2; rabbit anti- polyclonal
claudin-3; mouse monoclonal anti-claudin-10; mouse monoclonal anti-claudin-15 and
rabbit polyclonal anti-claudin 15; mouse monoclonal anti-occludin; mouse monoclonal
anti-ZO-1; and mouse monoclonal anti- α-tubulin (Invitrogen Corporation, Camarillo,
CA); goat polyclonal anti-claudin-9 (Santa Cruz Biotechnology, Inc. Santa Cruz, CA);
mouse monoclonal anti-human claudin-12 (R&D Systems, Inc, Minneapolis, MN); rabbit
polyclonal anti-claudin-16 (Abcam, Cambridge, MA); or rabbit polyclonal anti-claudin19 (gift from Mikio Furuse, Kobe University, Kobe, Japan). Human kidney protein (GBiosciences, St. Louis, MO) were used as a positive control in some experiments. Blots
were developed with HRP conjugated secondary antibodies and ECL plus
chemiluminescence reagent (Amersham Life Science, Arlington Heights, IL) and imaged
with ChemiDoc XRS System (BioRad).
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Protein electrophoresis was performed in collaboration with Shaomin Peng.

Immunofluorescence

Claudin, ZO-1, and occludin protein localization were evaluated through indirect
immunofluorescence. Samples were fixed using 100% ethanol at 4°C for 15 min two
times. Cells were then exposed to the primary antibodies listed above for
immunoblotting. Samples were also counter labeled with mouse anti-occludin or mouse
anti-ZO-1 (Invitrogen Corporation, Camarillo, CA). Secondary antibodies used were MLgrade secondary antibodies conjugated with Cy3 or Cy5 dyes (Jackson ImmunoResearch
Laboratories, West Grove, PA). Alexa Fluor 488 phalloidin was used to label F-actin and
DAPI was used to label nuclei. Images were obtained using an Axioskop or a LSM 410
spinning-disc confocal microscope and processed using AxioVision software (Carl Zeiss,
Inc, Thornwood, NY).

Immunofluorescent staining of cell cultures was performed in collaboration with
Shaomin Peng. Images shown here were obtained by Shaomin Peng and Lawrence J.
Rizzolo.
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Small Interfering RNA (siRNA) Transfection

Established siRNAs specific for claudins 2, 3, 4, 10, and 19 were acquired from
Dharmacon (siGENOME SMARTpool; Lafayette, CO); for each claudin, a pool of 4
siRNAs specific for that respective claudin was utilized. hfRPE cells were prepared for
siRNA transfection by washing and incubation in antibiotic-free serum-free medium for 2
hours. Cells were then transfected with the claudin siRNA of interest (0.025µM final
concentration) per the manufacturer’s protocol using DharmaFECT 4 transfection reagent
(Dharmacon, Lafayette, CO). Transfection with claudin 4 siRNA served as a control
because claudin 4 is not expressed by hfRPE(71). Cells were incubated with siRNA for
24 hours, after which they were switched back to either growth medium or serum-free
medium for the duration of the experiment. Claudin 19 siRNA experiments were
harvested at 3 days, 5 days, 7 days, and 21 days post-transfection. Claudin 3 siRNA
experiments were harvested at 5 and 7 days post-transfection. To assess the possible
relationship between TNF-α and claudin 2, cells were treated with claudin 2 siRNA as
described. Nine days following transfection, after significant claudin 2 mRNA level
reduction, some of these cells were then exposed to TNF-α for 48 hours and then
harvested. Additionally, we performed a double siRNA transfection with claudin 19
siRNA using the methods described above except with siRNA transfection at both days 0
and 3 with harvest at day 6.

The experiment and transfection protocol was designed in collaboration with Shaomin
Peng. The siRNA transfection itself was performed by Shaomin Peng.
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Gene

Upstream

Downstream
CAATGACAGCCATCCACATC

Siz
e
Location(bp)

Claudin-1

CTGCCCCAGTGGAGGATTTA

Claudin-2

ACACACAGCACAGGCATCAC TCTCCAATCTCAAATTTCATGC

490-809 319

Claudin-3

AAGGTGTACGACTCGCTGCT

Claudin-4

TGGATGAACTGCGTGGTGCAG GAGGCGGCCCAGCCGACGTA

Claudin-5

ATGTCGTGCGTGGTGCAGAG GGTGCAGACCCAGGCGCCGCA

189-436 247
27533114 361
14591872 413

Claudin-6

GATGCAGTGCAAGGTGTACG CCTTGGAATCCTTCTCCTCC

183-343 160

Claudin-7

AGTGGCAGATGAGCTCCTATG GTTATAAAAGTCTGTGACAATCT

404-768 364

Claudin-8

GAAGGACTGTGGATGAATTGC GATGAAGATGATTCCAGCCG

Claudin-9

TTCATCGGCAACAGCATCGT

142-381 239
9541357 403

AGTCCCGGATAATGGTGTTG

GCCCAGCCCAGGTAGAGGGA

107-392 285

Claudin-10 TGTACCAAAGTCGGAGGCTC GCATTTTTATCAAACTGTTTTGAAGG 307-677 370
Claudin-10a GCGGCGCGACATGTCCAGG

CGAGCTCTTTTAGACATAAGC

226-926 700

Claudin-10b CCGGCGGCATGGCTAGCA

CGAGCTCTTTTAGACATAAGC

54-758 704

Claudin-11 TGGTGGACATCCTCATCC

AGAGAGCCAGCAGAATGAGC

203-397 194

Claudin-12 TTCCTTCCTGTGTGGAATCG

GTTGCACATTCCAATCAGGC

Claudin-14 CTCATGGTCATCTCCTGCCTG ACGTAGTCGTTCAGCCTGTAC

181-475 294
10501519 469

Claudin-15 AGGAAGCAGAGAGACCCACA AGAACCCCTAGGGAACTGGA

50-200 155

Claudin-16 TTTGGATTTCTCACCCTGCTC TGTGCGAGGGGCTGAGTATGA

481-879 398

Claudin-17 TGCTTATTGGCATCTGTGGC

TTCTGACCTATGTGGATGGC

284-473 189

Claudin-18 GATGATCGTAGGCATCGTCC

ATGCCGGTGTACATGTTAGC

246-473 227

Claudin-19 CTCAGCGTAGTTGGCATGAA GAAGAACTCCTGGGTCACCA

289-447 159

Claudin-20 TCCCAGGCTTTGTTATTTGG

CCAGATAAGGCCAGGATGAA

271-431 160

GAPDH

TCACCAGGGCTGCTTTTAAC

GACAAGCTTCCCGTTCTCAG

Occludin

GAAGCCAAAACCTCTGRGAGC GAAGACATCGTCTGGGGTGT

51-204 153
20942323 229

Location is numbered from the initiation codon. Genbank Accession numbers:
Claudin-1, NM_021101; Claudin-2, NM_020384; Claudin-3, NM_001306; Claudin-4,
NM_001305; Claudin-5, NM_003277; Claudin-6, NM_021195; Claudin-7, NM_001307;
Claudin-8, NM_199328; Claudin-9, NM_020982; Claudin-10, NM_006984; Claudin-11,
NM_005602; Claudin-12,. NM_012129; Claudin-14, NM_012130; Claudin-15, NM_014343;
Claudin-16, NM_006580; Claudin-17 NM_006580; Claudin-18, NM_001002026; Claudin-19,
NG_008993; Claudin-20, NM_001001346; GAPDH NM_002046; Occludin NM_002538.2

Table 1. Primers used for RT-PCR and Real-Time RT-PCR. Table adapted from Peng et
al (2010) (42).
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Results

In this study, we use hfRPE to model the outer blood-retinal barrier in AMD. Elements of
AMD studied are 1) the effects of serum, as may play a role in neovascular AMD and 2)
the consequences of proinflammatory cytokines, which may be present in both
neovascular and non-neovascular AMD. To assess effects on the outer blood-retinal
barrier, we focus on tight junctions and thus the major tight junction proteins, the claudin
family and occludin. Effects were measured on the functional level (TER, permeability,
conductance), mRNA level (quantitative, real-time RT-PCR), and protein level
(immunoblotting, immunofluorescence) as detailed in the Methods.

Functional changes secondary to changes in culture media
Following a period of 6-8 weeks, hfRPE cultures maintained in growth medium
stabilized to a TER of ~900-1400 Ω×cm2 from their initially low levels (35,71).
Throughout this process, cells also visibly resumed melanin production. Once TER levels
stabilized, they remained relatively constant for months, allowing experimentation.
Cultures at that point could either continue maintenance in growth medium or could be
switched to serum-free medium as described in Methods. After switching to serum-free
medium, TER of the cultures decreased for approximately 4 weeks until stabilization at a
TER of ~250-400 Ω×cm2 (Figure 4). Again, TER remained stable for months after
reaching this plateau in TER. If returned to growth media, these cells returned to
approximately 85% of their previously higher TER levels (data not shown).

23
To further investigate if these potential effects were secondary to these two different base
media and/or serum levels, we exposed cultures to a series of different culture conditions.
Regarding growth media, cultures appeared to maintain TER ~1250 Ω×cm2 regardless of
the concentration of serum (5% vs. 1%). With respect to serum-free medium, cultures did
have significantly lower TER levels when compared to those cultured in growth media.
This reduction was more moderate when serum was added to the culture medium (SF +
1% in Figure 4).

To model neovacular AMD, we added 5% FBS to our serum-free model in either the
apical media chamber (corresponding to the subretinal space), basal media chamber
(corresponding to the choroidal space), or both media chambers (Figure 4). When serum
was added to the apical media chamber, where serum might be present in neovascular
AMD, TER increased to levels approximately 50% of those in growth medium. In
contrast, serum added to the basal media chamber, corresponding to the choroidal space
where serum may normally be expected, there was no significant change in TER. For
cultures in which serum was added to both media chambers, the result was intermediate.
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Figure 4: TER following exposure to different culture conditions (a) and the addition of
serum (b). hfRPE cultures were maintained in growth medium until TER remained stable.
(a) After stabilization of TER, cultures were either continued in growth medium or were
switched to an alternate medium as noted. Cells switched to a serum-free medium
gradually decreased in TER as shown. (b) Following stabilization of TER in serum-free
medium, on day 35, serum-free medium cultures were either continued as previously or
were switched to alternate media as follows: serum-free medium with 5% FBS added to
the apical chamber with serum-free medium in the basal chamber; serum-free medium
with 5% FBS added to the basal chamber with serum-free medium in the apical chamber;
or serum-free medium with 5% added to both apical and basal medium chambers. TER
increased when serum was added to the apical medium chamber but remained stable
when serum was added to the basal chamber; cultures with serum added to both chambers
had an intermediate TER. The TER of native hfRPE ± S.E.M. is shown with a gray bar
(32). Error bars show S.E.M. with n = 4-6 filters. GM, growth medium; SFM, serum-free
medium. Figure from Peng et al 2010 (42).

Since TER is a measurement encompassing both transcellular and paracellular transport
mechanisms, we further studied paracellular transport by measuring TER under specific
media conditions that minimized transmembrane transport (73). TER was measured in
either NaCl or KCl solution; the absence of either Na+ or K+ would inhibit the Na+,K+ATPase and thus reduce coporter and antiporter activity. Each solution also included
BaCl2, as barium inhibits K+ transport, and lacked CO2 to inhibit bicarbonate cotransport.
Conductance (G), which reflects the interactions of ions with the tight junctions, was then
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calculated as 1/TER; G is presented here to show the relative selectivity for Na+ or K+
(Figure 5). For cells grown in varying media conditions (Figure 5a), those cultured in
serum-free medium have greater G versus those cultured in growth medium.
Additionally, the addition of serum to serum-free medium appears to temper that effect.
When examining GNa+/GK+, this value is 0.3 in growth medium cultures (consistent with
previous data) (71). This value increases to 0.9 in cultures grown in serum-free medium,
showing the affects of media conditions on conductivity. Also, serum added to the apical
chamber of the culture increases GNa+/GK+ significantly; this effect is not seen if serum
was added to the basal chamber or both media chambers.

Figure 5: Conductance following exposure to different media and serum conditions. To
estimate conductance, TER was measured in buffered solutions containing either NaCl or
KCl, containing BaCl2, and not containing CO2 to inhibit transcellular transport as
described in Methods. Conductance, shown below, was calculated as the inverse of TER.
For all experiments, n = 3 and error bars show S.E.M. Figure from Peng et al 2010 (42).
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To further characterize paracellular transport, we examined the diffusion mPEG, a
nonionic tracer with no transmembrane transporters. Generally, nonionic tracers with a
Stoke’s radius less than 4 Å, such as mPEG350, can diffuse through tight junction pores
while tracers with Stoke’s radius greater than 4 Å, such as mPEG550, need tight junction
strands to transiently break and reseal to allow their passage (see Figure 1) (74). Because
mPEG550 is dependent upon strand breakage for transport, a change in the rate of such
breaking and resealing would have a greater effect on mPEG550. Also, diffusion across
tight junctions is bidirectional so the ratio of P550/P350 is theoretically the same in both
apical-to-basal-and basal-to-apical directions. For cultures maintained in growth medium
(Figure 6), the ratio of P550/P350 was the same for both concentration gradients; this ratio
was also the same as the ratio for serum-free cultures in the basal-to-apical direction.
However, for serum-free cultures, the ratio was dependent upon concentration gradient,
and P550/P350 was higher in the apical-to-basal direction. P550 was twice as high in the
apical-to-basal direction (0.0038 ± 0.0003 cm/hr vs. 0.0018 ± 0.0002 cm/hr, p < 0.01).

The diffusion of mPEG was also examined in serum-free cultures with serum added to
the apical and/or basal medium chambers. Cultures with serum added to the apical
chamber had a lower P550/P350 and those with serum added to the basal chamber had a
greater P550/P350. Lastly, in order to minimize affects of transcytosis in all experiments,
the data presented were measured in the presence of NH4Cl (10 mM), which should
inhibit receptor-mediated transcytosis. Absence of NH4Cl did not alter our results (data
not shown).
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Figure 6: Permeability of hfRPE. Permeability was measured using the apparent
permeation coefficient for mPEG550 compared to mPEG350. The measurements were
made in the apical-to-basal direction (dark gray) or basal-to-apical direction (light gray).
When measured in the apical-to-basal direction, P550 and P550/P350 were greater when
serum was not present in the apical chamber. The presence or absence of serum had little
effect on permeability when measured in the basal-to-apical direction. For all
experiments, n = 3 and error bars represent S.E.M. Figure from Peng et al 2010 (42).

Response of claudin and occludin mRNA to serum alterations
The mRNA expression profile of the claudin family and occludin was measured using
quantitative, real-time RT-PCR as described in Methods. To determine mRNA
expression levels of in native tissue, RPE was freshly isolated from four fetuses aged
between 15 and 16 weeks (Figure 7). Claudin 19 was found to be the most abundant
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claudin. Claudin 3 and claudin 12 were also found in considerable levels (25% of claudin
19 levels and 7% of claudin 19 levels, respectively). All other claudins were detected in
much lower amounts ≥ 85× less than claudin 19 expression. Claudin 16 was found to
have the lowest expression level at more than 3,000× less than claudin 19 levels.

Of the claudins, claudin 10 is known to have two isoforms (75): claudin 10a and claudin
10b. To determine the isoform(s) of claudin 10 found in hfRPE, the total RNA described
above was subjected to RT-PCR with primers specific to either isoform (Figure 7b).
Results show hfRPE expresses claudin 10b and does not express claudin 10a. Human
kidney RNA was used as a positive control.

Figure 7: Native expression of claudin and occludin mRNA in freshly isolated hfRPE. (a)
Total RNA was derived from four fetuses; mRNA expression was determined using
quantitative, real-time RT-PCR. Data presented were normalized to GAPDH and levels
are represented relative to claudin 19 (the predominant claudin). All experiments were
repeated three times and error bars represent S.E.M. (b) Claudin 10 isoforms were
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analyzed using RT-PCR with primers specific for either claudin 10a or claudin 10b.
Human kidney RNA was used as a positive control for both isoforms. Size markers
shown are a Hae III digest of phiX174 with sizes (bp): 1353, 1078, 872, and 603. CLDN,
claudin. Figure from Peng et al 2010 (42).

Following the characterization of claudin and occludin mRNA expression in native
tissue, we determined this profile in vitro (Figure 8). The expression profiles of both
native and in vitro hfRPE were similar. Again, claudin 19 was the predominant claudin
with levels greater than 20× higher than any other claudin, followed by claudin 12 and
claudin 3. Notably, although claudin 12 mRNA had a high expression level,
approximately 3× less than that of claudin 19, this claudin could not be detected through
immunoblotting or immunofluorescence. In comparison to native RPE, claudins 1, 3, 15,
and 20 were under-expressed in culture. Claudin 10 was notably over-expressed,
particularly in serum-free medium cells. Again, in culture, the isoform of claudin 10 seen
was claudin 10b and not claudin 10a (Figure 7). Claudin 2 was over-expressed in serumfree medium cells.

Changes in culture conditions did not appear to effect the mRNA expression of most
claudins. However, claudins 1, 2, and 10 all had lower expression levels when cultured in
growth medium versus serum-free medium. More specifically, in growth medium
containing only 1% serum, claudin 1 mRNA was particularly low. Claudin 16 was
overexpressed in culture with serum-free medium versus our native samples; this
expression was lower under all other culture conditions, bringing claudin 16 mRNA
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expression to the levels seen in native tissue. To simulate neovascular AMD, the addition
of serum to the apical, basal, or both media chambers was performed per Methods. These
serum alterations appeared to increase claudin 10 and occludin when added to either or
both media chambers (Figure 8). The mRNA of the other claudins were unaffected by
these interventions.

Figure 8: Claudin and occludin mRNA expression in vitro. hfRPE was isolated from two
fetuses and was cultured separately. Total RNA was subsequently isolated from each
culture and claudin and occludin mRNA expression was measured using quantitative
real-time RT-PCR. Results were normalized to GAPDH. Each experiment was performed
in triplicate. (a) mRNA expression patterns in growth medium versus serum-free
medium. All mRNA levels are shown relative to claudin 19 expression. Horizontal bars
show the mRNA expression of each respective gene in native tissue. Error bars represent
S.E.M. (b) mRNA expression patterns following addition of serum to the apical, basal, or
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both sides of the model. All mRNA levels are shown relative to expression in serum-free
medium. Cldn, claudin. Figure from Peng et al 2010 (42).

Response of claudin and occludin protein to culture conditions
Immunoblotting was performed on all cultured hfRPE samples to determine potential
effects of varying culture and/or serum conditions on claudin protein levels (Figure 9).
These immunoblots revealed regulation of certain claudins at the protein level. Claudin 1
protein levels increased with the addition of serum to serum-free medium (change not
seen at the mRNA level, as noted above). Notably, claudin 1 protein levels also increased
when serum was added to the apical medium chamber and not when medium was added
to the basal chamber. This effect was also seen when serum was added to both media
chambers. Although claudin 10 mRNA levels were higher in growth medium-maintained
cultures versus serum-free medium cultures, this increase was not reflected at the protein
level. For both mRNA and protein, claudin 2 was seen in higher levels in serum-free
medium. At the protein level, claudin 3 appeared to have greater levels when serum was
added to the apical medium chamber. Claudin 19, the predominant claudin, did not
experience changes in either mRNA or protein levels with varying culture conditions.
Claudins not shown below were either not detected by immunoblotting or the background
on their immunoblots was too high to produce reliable results. α-tubulin was used as a
loading control and shows equal amounts of protein in each well.
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Figure 9: Claudin protein expression. Expression of claudins 1, 2, 3, and 19 under
varying media conditions: growth medium with 5% serum; growth medium with 1%
serum; serum-free medium with 1% serum; serum-free medium with no serum; serumfree medium with 5% FBS added to the apical medium chamber; serum-free medium
with 5% FBS added to the basal medium chamber; or serum-free medium with 5% FBS
added to both media chambers. The immunoblots shown below are representative of
immunoblots performed for protein extracted from multiple samples. α-tubulin served as
a loading control. Notably, serum in the apical chamber increases the expression of both
claudin 1 and claudin 3 but does not have a clear effect on claudins 2 or 19. GM, growth
medium;

SFM,

serum-free

medium.

Figure

from

Peng

et

al

2010

(42).

At the protein level, occludin showed remarkable changes in steady-state protein levels.
Occludin levels were markedly lower in serum-free medium vs. other conditions (Figure
10). When serum was added to the apical chamber of the model, occludin expression
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increased; occludin levels remained stable if serum was added to only the basal medium
chamber. This effect was different than that seen at the mRNA level, where occludin
mRNA increased when serum was added to either the apical or the basal side of the
model. Post-translational phosphorylation of occludin is reflected by slower migration on
gel electrophoresis. When compared to occludin from human kidney, slower migrating
isoforms of occludin were seen in hfRPE and there was no evidence on immunoblots that
interventions led to post-translational modifications. α-tubulin was used as a loading
control and shows equal amounts of protein in each well.

Figure 10: Occludin protein expression under varying culture conditions. The conditions
are as described in Figure 9 above. The immunoblots shown below are representative of
immunoblots performed for protein extracted from multiple samples. α-tubulin served as
a loading control. Occludin expression was greatest when cultures were exposed to serum
in the apical medium chamber. Only high Mr isoforms are seen. GM, growth medium;
SFM, serum-free medium. Figure from Peng et al 2010 (42).
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Immunofluoresence helped characterize the protein localization of several claudins,
occludin, actin, and ZO-1. Both claudin 3 and claudin 19 were expressed consistently by
all cells at the apical tight junctions; this agrees with prior studies (71). Claudins 1 and 10
were expressed heterogeneously. Claudin 1 was expressed at greater levels in some
samples in comparison to others. For example, one hfRPE culture showed staining for
claudin 1 in very few cells while another culture from a different fetus showed patches of
claudin 1-staining RPE. Evaluated on three-dimensional reconstructions, it is seen that
claudin 1 localizes to the apical junctional complex when it can be detected (Figure 11
claudin 1-expressing cells are indicated with a white arrow). With respect to claudin 10, it
consistently showed greater expression levels in serum-free medium. In growth medium,
claudin 10 localized to the tight junctions but was seen only in a subset of cells. However,
in serum-free medium, claudin 10 was seen in a grossly larger percentage of cells (Figure
12). Claudins 2, 12, 15, 16, and 20 were all below the threshold for detection by
immunofluorescence and are thus not shown here.
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Figure 11: Claudin, occludin, ZO-1 and actin protein expression under varying culture
conditions. hfRPE cultured in either growth medium or serum-free medium were doublelabeled for claudin, occludin, ZO-1, or actin, as shown, and visualized with confocal
microscopy. ZO-1, actin, and occludin were all expressed but are not always imaged here
secondary to the confocal filter moving in and out of the confocal plane. All claudins are
shown in red, counter-labels are shown in green, and areas of co-localization appear
yellow. Nuclei are shown in blue. Both claudin 3 and claudin 19 were seen in all cells;
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claudin 1 and claudin 10 were seen in only some cells with more cells expressing these
claudins in serum-free medium preparations. Arrows show claudin 1- expressing cells.
The white bar signifies 20 µm. Figure from Peng et al 2010 (42).

Figure 12: Claudin 1 colocalized with occludin. hfRPE cultured in serum-free medium
was double labeled for claudin 1 (red) and occludin (green). This three-dimensional
reconstruction shows claudin 1 and occludin co-localizing to apical tight junctions (colocalization appears orange). Cells grown in growth medium showed similar results.
Figure from Peng et al 2010 (42).

Knockdown of claudin 19 and claudin 3 with siRNA
To better decipher the role of claudins 19 and 3 in the outer blood-retinal barrier, we
utilized siRNA targeting these claudins to inhibit their expression. Transfection of growth
medium cultures with claudin 19-specific siRNA resulted in effective knockdown of
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claudin 19 expression (Figure 13). This decrease in claudin 19 expression correlated with
a significant decrease in TER levels, suggesting an apparent disruption in tight junction
function in these cultures. Five days post-transfection, cultures with claudin 19
knockdown had a TER of ~20-25 Ω×cm2, down from approximately ~1200 Ω×cm2.
These low TER levels remained stable and without recovery over the following 21 days.
For cells treated with a mock transfection (exposure to transfection reagent and no
siRNA), with a transfection with an siRNA specific for a claudin unexpressed by hfRPE
(claudin 4), or with a transfection with an siRNA specific for a minor claudin (claudin 2
or claudin 10, data not shown), a transient 5-10% decrease in TER was seen.

Five days post-transfection with claudin 19-specific siRNA, claudin 19 levels were
decreased 20-25× (Figure 13). At this time, claudin 19 signals were also decreased by
immunoblotting and by immunofluoresence (Figures 14, 15). This decrease was
accompanied by small compensatory increases of minor claudin mRNAs and proteins.
Specifically, claudin 1 mRNA showed a 3.5× increase following claudin 19 knockdown
and a small increase in protein expression. Claudin 2 mRNA showed a 4× increase in
mRNA levels, a small increase in protein levels on immunoblot, but no
immunofluoresence signal. Seven days post-transfection with claudin 19-specific siRNA,
claudin 19 mRNA levels recovered to only 5× less than pretransfection levels. To test
potential further knockdown of claudin 19, a sequential knockdown was performed by
transfecting cells twice, two days apart; this experiment showed claudin 19 levels
decreased almost 40× (data not shown). Transfection with an irrelevant siRNA (claudin
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4) or exposure to only the transfection reagent had less than a four-fold effect on the
expression of occludin or any claudin barring claudin 19.

Although TER remained low following claudin 19 knockdown, the protein remained
detectable by immunofluoresence 21 days following transfection. An intact monolayer
could be seen with proper polygonal cell morphology. The tight junction proteins claudin
19, claudin 3, actin, ZO-1, and occludin all remained localized to the apical junctional
complex. Interestingly, these results are similar to those seen with freshly plated hfRPE,
before a monolayer develops with an appreciable TER (data not shown).

Transfection of hfRPE cultures with an siRNA specific to claudin 3 showed minimal
effects. Knockdown of claudin 3 at the mRNA level was minimal and there was little
change on TER and/or ion selectivity. Protein levels, however, did show a decrease both
five and seven days post-transfection.

Transfection efficiency with siRNAs was markedly lower for cells maintained in serumfree medium. Knockdown of claudin 19 following transfection with its siRNA resulted in
only a 2-3× decrease in its mRNA levels. Immunofluoresence examination of these
cultures showed reduced claudin 19 expression in a subset of cells, but not in all cells
(data not shown). However, even this mild decrease in claudin 19 expression resulted in a
reduced TER to the level of ~50 Ω×cm2.
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Figure 13: Claudin and occludin mRNA expression following claudin 19 knockdown.
hfRPE cultured in growth medium were transfected with an siRNA targeting claudin 19.
Total RNA was extracted from these samples and mRNA expression was measured using
quantitative real-time RT-PCR. As a control, cells were transfected with an siRNA
targeting claudin 4, a claudin which is not expressed in hfRPE. Data was normalized to
GAPDH and is presented relative to control mRNA expression values. (a) Time-course of
claudin 19 mRNA expression following claudin 19 siRNA transfection (b) Claudin and
occludin mRNA expression five days post-claudin 19 siRNA transfection. Only claudin 1
shows a greater than 2× change in expression. Error bars represent the range of averages
from two independent experiments performed in triplicate. Figure from Peng et al 2010
(42).
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Figure 14: Claudin protein expression following claudin siRNA knockdown. (a) Claudin
19 siRNA knockdown. Protein was extracted from samples five days post-tranfection and
immunoblotted. Samples were either: control (cultured in growth medium); reagent
(mock-transfected without any siRNA); siRNA claudin 4 (transfected with siRNA
targeting claudin 4); or siRNA claudin 19 (transfected with siRNA targeting claudin 19).
Knockdown of claudin 19 using siRNA resulted in reduction of claudin 19 protein but did
not affect the expression of other claudins. (b) Claudin 3 siRNA knockdown. Protein was
extracted from samples five or seven days post-transfection and immunoblotted as
labeled. Samples were either: siRNA claudin 4 (transfected with siRNA targeting claudin
4); siRNA claudin 3 (transfected with siRNA targeting claudin 3); or reagent (mocktransfected). Figure from Peng et al 2010 (42).
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Figure 15: Claudin 3, claudin 19, and occludin protein expression following claudin 19
knockdown. Each respective claudin is labeled in red and the counterlabel is green.
Claudins, occludin, actin, and ZO-1 co-localize at the apical tight junctions despite TER
only ~20 Ω×cm2. Claudin 19 protein expression is lower here than seen without siRNA
knockdown. The white bar represents 10 µm. Figure from Peng et al 2010 (42).

Alterations in function following cytokine exposure
After exposure to either TNF-α, IL-1β, or INF-γ for 48 hours, TER of hfRPE cultures
was measured. Exposure to TNF-α resulted in the most dramatic alterations in TER,
regularly causing an approximately an 85% decrease in cultures maintained in growth
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medium and approximately a 70% decrease in cultures maintained in serum-free medium.
INF-γ showed more variable results: in one growth medium sample, exposure to INF-γ
resulted in an almost 20% decrease in TER, while the other samples showed no marked
change in TER. With respect to serum-free medium, INF-γ exposure resulted in a 32%
decrease in TER in one sample but in no major alteration in TER in the other two
samples. Finally, IL-1β consistently showed little effect on TER in either growth medium
or serum-free medium maintained cultures.

% of Control TER
Growth Medium

Serum-free Medium

Sample

Sample

Sample

Sample

Sample

Sample

1

2

3

1

2

3

TNF-α

16.5

14.7

8.1

25.9

33.3

14.2

IL-1β

86.5

93.3

101.3

93.4

100.4

103.8

INF-γ

93.9

82.4

101.4

68.1

94.1

104.7

1301

1041

1491

453

479

887

TER of Control
2

(Ω×cm )

Table 2: TER following exposure to TNF-α, IL-1β, or INF-γ for 48 hours. For each
cytokine, n = 3 and standard error < 5%. Table adapted from Peng et al (in preparation).
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When examining ion selectivity following exposure to each cytokine for 48 hours,
several effects were noted. In growth medium, TNF-α increased GNa+/GK+ from 0.6 to
0.8; in serum-free medium, TNF-α also increased GNa+/GK+, this time from 0.8 to 1.0. In
preparations for which INFγ had an effect on TER, its alterations on ion selectivity were
similar to those of TNF-α. Consistent with TER data, exposure to IL-1β resulted in little
effect on ion selectivity.

Figure 16: Ion selectivity following exposure to TNF-α, IL-1β, or INF-γ for 48 hours.
Conductance was estimated as the inverse of TER. Conductance was measured in either
buffered NaCl or KCl; the ratios were unaffected by the order in which measurements
were made. For each cytokine, n = 3. An * denotes p < 0.05 compared to the control.
Figure from Peng et al (in preparation).
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Effects of cytokines on claudin and occludin mRNA
Exposure of cultures to proinflammatory cytokines generally showed mRNA effects
which were less than two-fold, which we considered likely not biologically significant.
However, some effects on mRNA expression were evident (Figure 17). TNF-α increased
the expression of claudin 2 approximately 3× while decreasing the expression of claudin
10 (~30×) and claudin 19 (~5×). Exposure to INFγ resulted in reduced mRNA expression
of claudin-2 (6×), -3 (4×) and -10 (8×). Similar to its variable effects on TER, the effects
of exposure to INFγ were inconsistent. Like IL-1β produced little effect on TER levels,
exposure to this cytokine also resulted in few effects on claudin or occludin mRNAs.

Figure 17: Claudin and occludin mRNA expression following cytokine exposure for 48
hours. mRNA expression was measured using real-time RT-PCR and is presented for
each gene relative to mRNA expression in control cultures. Claudin 19 and occludin
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show the highest mRNA expression levels, 10-3000× higher than other genes. Claudin 16
shows the lowest expression. Overall, cytokines appear to have little effect on mRNA
expression, particularly of claudin 19 and occludin. The * denotes error bars that show
the range of two independent preparations of hfRPE (n=2). For the remaining genes, error
bars show the standard error for three independent preparations of hfRPE (n=3). Every
preparation was measured in triplicate. Figure from Peng et al (in preparation).

Effects of cytokines on claudin and occludin protein
When protein expression levels were examined, the greatest effects were seen with TNFα exposure. TNF-α increased the expression of both claudin 1 and claudin 2 while
decreasing the expression of claudin 19 in both culture media (Figure 18). Meanwhile,
claudin 3 expression was reduced following exposure to TNF-α in growth medium. A
visible background band was enhanced by TNF-α in all immunoblots. With exposure to
IL-1β and IFN-γ, claudin 1 protein expression showed a slight increase in growth
medium but no change in serum-free medium. Claudin 3 was decreased following
exposure to IL-1β and IFN-γ in growth medium; this change was not observed in serumfree medium. Treatment with IL-1β and IFN-γ did not have any effect on claudin 19
protein levels. α−tubulin was used as a loading control and shows loading of equal
protein amounts for each sample. Occludin protein levels were generally lower in serumfree cultures versus growth medium cultures. Both TNF-α and INF-γ reduced occludin
expression in growth medium cultures but no cytokines showed effects in serum-free
medium. Again, α−tubulin was used as a loading control and shows loading of equal
protein amounts for each sample.
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Figure 18: Protein expression levels following exposure to TNF-α, IL-1β, or INF-γ for 48
hours. Protein levels were determined by immunoblotting. α-tubulin served as a control.
Each experiment was performed in triplicate and representative blots are shown here. (a)
The known position of each claudin protein is marked with a black bar to the left of each
immunoblot. A slower migrating background band is enhanced by TNF-α in all blots.
TNF-α appears to increase claudin 1 and claudin 2 expression and decrease claudin 19
expression. IL-1β appears to increase claudin 1 expression. Neither IL-1β nor INF-γ
appear to have an effect on claudin 19. (b) Occludin protein levels appear lower in serumfree cultures versus growth medium cultures. Both TNF-α and INF-γ lowered occludin
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expression in growth medium but cytokines showed no effects in serum-free medium.
From Peng et al (in preparation).
These changes in protein expression were further examined using immunofluorescence
microscopy. In control cells, claudin 1 was seen in a subset of cells; in contrast to the
increase seen in claudin 1 levels following TNF-α exposure in immunoblotting,
immunofluoresence did not show an increase in the number of cells staining for claudin 1
with TNF-α treatment. However, following TNF-α exposure, tight junctions appeared
tortuous and apical stress fibers were apparent. Immunoblotting showed a slight increase
in claudin 1 levels following INFγ treatment and, by immunofluorescence, the
localization of claudin 1 was affected and the claudin was seen less frequently at the tight
junctions. IL-1β exposure did not appear to have significant effects on claudin 1
localization.

Figure 19: Effects of cytokine exposure on claudin 1 and actin protein expression.
Following exposure of growth medium-incubated cells to each respective cytokine for 48
hours, cells were labeled and imaged using confocal microscopy. For each image, the
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fluorescence channels were merged to produce a maximum projection image. Actin is
shown in green and was expressed in both the apical junctional complexes and microvilli.
Claudin 1 is labeled red and was expressed in a subset of cells, indicated by small arrows.
Nuclei are shown in blue. Colocalization of the proteins is shown in orange. Tight
junctions appeared tortuous following TNF-α exposure and stress fibers were seen
(shown with a large arrow, magnified in the inset). Neither IL-1β nor INF-γ showed
effects. For estimation of size, the white bar denotes 20 µm. From Peng et al (in
preparation).

Immunostaining for claudin 2 rarely revealed this claudin in control cells. However,
correlating with immunoblotting results, claudin 2 expression was regularly seen
following TNF-α exposure (Figure 20). Three-dimensionally rendered confocal images
of TNF-α exposed cells show claudin 2 (red) at the apical tight junctions co-localized
with occludin, actin, and ZO-1 (Figure 21). In Figure 21, the image is presented at an
angle to better reveal the apical and lateral surfaces of the monolayer.

Examination of occludin protein localization showed control cells consistently expressing
this protein at their apical tight junctions. TNF-α exposure showed effects on occludin
localization, which were dependent on the culture medium. For cells maintained in
growth medium, TNF-α exposure resulted in reduction of occludin levels. The occludin
expressed, however, was localized to the apical tight junctions. For cells maintained in
serum-free medium, the reductions in occludin expression seen by immunoblot were
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greater, although the protein could still be visualized by immunofluorescence (data not
shown).

Claudin 3 was consistently visualized at the tight junctions of control cells (seen in red,
Figure 22). The co-localization of claudin 3 with actin at the tight junctions can be
regularly visualized in these cells as an orange color. A similar pattern was seen in
cultures exposed to INF-γ, although claudin 3 levels had appeared lower following
exposure to this cytokine by immunoblot. Visualization of claudin 3 following TNF-α
and IL-1β exposure agreed with immunoblot results and showed generally decreased
expression of claudin 3.

Claudin 19 expression was consistently seen at the tight junctions of control cells (Figure
23). Expression of this predominant claudin remained strong following treatment with
either IL-1β or INF-γ. By contrast, exposure to TNF-α resulted in reduced expression of
claudin 19, which corresponds with the reductions seen at the mRNA level and by
immunoblot.

Claudin 10 expression was below the threshold for detection in control cells and
following exposure to all three cytokines (data not shown).

Of note, TNF-α exposure consistently resulted in morphological changes of the cells.
Following exposure, tight junctions appeared tortuous rather than straight (Figure 21).
Entire individual cells also were affected, showing an irregular shape different from the
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typical polygonal shape. Cells exhibited apical stress fibers containing actin; such stress
fibers have been previously shown in epithelia, including RPE, during wound-healing
(32, 72-74).

Figure 20: Effects of cytokine exposure on claudin 2, occludin, and actin protein
expression. Cells grown in either growth medium or serum-free medium were exposed to
each respective cytokine for 48 hours. The cells were then labeled and imaged using
confocal microscopy. For each image, the fluorescence channels were merged to produce
a maximum projection image. Claudin 2 was labeled in red, but this signal was below the
threshold for detection in all samples except in some cells exposed to TNF-α (small
arrows). Growth media cells were counter-labeled for occludin (green); this signal was
weaker for TNF-α exposed cells. Serum-free media cells were counter-labeled for actin
(green) found in apical stress fibers (large arrows) and in tight junctions). Nuclei were
labeled in blue using DAPI as noted in Methods. For estimation of size, the white bar
denotes 20 µm. From Peng et al (in preparation).
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Figure 21: Visualization of claudin 2 in the tight junctions of hfRPE. Claudin 2 protein
levels were increased following exposure to TNF-α, allowing its visualization through
confocal microscopy. The images below were captured using three-dimensional
rendering with the white box indicating the monolayer thickness. Color coding shows the
nucleus in blue, actin in green, claudin 2 in red (image A), or occludin in red (image B).
(a) In this image, the apical tight junctions can be seen with appropriate actin and claudin
2 labeling (occludin was turned off); co-localization of actin and claudin 2 is shown with
an orange signal. In this field, two cells show claudin 2 while the rest have claudin 2
levels below the threshold of detection. (b) The same field is shown, this time showing
actin and occludin (the claudin 2 channel was turned off). Co-localization of occludin and
actin are shown with an orange color. Actin can also be seen in the apical microvilli and
stress fibers (arrow). Nuclei show the depth of each cell and indicate that the tight
junctions are located apically. From Peng et al (in preparation).
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Figure 22: Effects of cytokine exposure on claudin 3. Cells were grown in growth
medium and exposed to each respective cytokine for 48 hours. The cells were then
labeled and imaged using confocal microscopy. For each image, the fluorescence
channels were merged to produce a maximum projection image. Claudin 3 was labeled in
red and actin was labeled in green. Areas in which the two proteins have co-localized
appear orange; this is particularly seen in control cultures and those exposed to INF-γ.
Cultures exposed to TNF-α or IL-1β show decreased expression of claudin 3, evidenced
by their predominantly green junctional complexes. Nuclei were labeled in blue using
DAPI. For estimation of size, the white bar denotes 20 µm. From Peng et al (in
preparation).
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Figure 23: Effects of cytokine exposure on claudin 19 protein expression. Cells were
grown in growth medium and exposed to each respective cytokine for 48 hours. The cells
were then labeled and imaged using confocal microscopy. For each image, the
fluorescence channels were merged to produce a maximum projection image. Claudin 19
was labeled in red and actin was labeled in green. Nuclei were labeled in blue using
DAPI. Cultures exposed to TNF-α show decreased claudin 19 expression while exposure
to the other cytokines shows no effect. For estimation of size, the white bar denotes 20
µm. From Peng et al (in preparation).

We further investigated the potential effects of TNF-α, and its increase in claudin 2, on
TER by knocking down claudin 2 expression. An siRNA targeting claudin 2 was able to
reduce claudin 2 mRNA expression 5-7× (data not shown). Corresponding reduction in
claudin 2 protein levels following siRNA knockdown were seen (Figure 24). When
exposed to TNF-α, these cells saw claudin 2 mRNA levels similar to those seen in
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control cells, but not the same high levels seen in other cells cultured with TNF-α.
However, even in these cells, TNF-α caused a reduction in TER similar to that seen in
cells not subjected to this claudin 2 knockdown.

Figure 24: Effect of TNF-α on claudin 2 expression following knockdown of claudin 2.
Claudin 2 was knocked down using transfection with siRNA targeting claudin-2 (Cldn2).
Knockdown against a claudin not expressed by hfRPE, claudin-4 (Cldn4), served as a
control. After claudin-2 levels were reduced (day 9 following transfection), cultures were
incubated with TNF-α for 48 hr. Following claudin 2 siRNA transfection with exposure
to TNF-α, claudin 2 mRNA levels were reduced 5-7×. siRNA had no effect on TER with
TER of control cells 1338 Ω×cm2 (n = 3 and standard error < 5%). From Peng et al (in
preparation).
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Discussion:

Here, we sought to adapt a human culture model of the outer blood-retinal barrier to
study both neovascular and non-neovascular AMD. In our characterization, we found
hfRPE to be a unique epithelium with claudin 19 as its predominant claudin in both
native hfRPE and cultured hfRPE. Notably, the composition and properties of our culture
model were somewhat dependent upon culture medium, with serum-free medium
appearing as a suitable option. When examining neovascular AMD in this model, apical
(subretinal) serum made tight junctions tighter. Investigation of proinflammatory
cytokines suggests these cytokines have differential effects on the tight junctions of the
outer blood-retinal barrier; of the cytokines tested, TNF-α was the only cytokine with
which exposure consistently resulted in leakier tight junctions.

Earlier work by other groups has shown that hfRPE can perform functions including
phagocytosis, process retinoids as part of the visual cycle, and polarize the distribution of
ion pumps and channels (35,36). This study shows that the tight junctions of hfRPE
additionally exhibit native characteristics. Both native hfRPE and cultured hfRPE express
the same profile of claudin and occludin mRNAs at similar levels. Importantly, both
native hfRPE and hfRPE in vitro express similar amounts of claudin 19 mRNA. Our
study reveals hfRPE utilizes claudin 19 as its major claudin, as discussed further below.
This result is further supported by prior genomics work showing claudin 19 is expressed
in the RPE but not in photoreceptors or choroidal cells (76). Of the minor claudins,
claudin 3 was seen in relatively high amounts in both native tissue and in culture. By
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immunofluorescence, claudin 3 protein was also seen in all cells. This may signal an
important role for claudin 3. Although other claudin mRNAs were detected in hfRPE,
their proteins were either expressed in subpopulations of cells or below the threshold for
detection by immunofluorescence. The heterogeneity in monolayer composition suggests
that the permeability and selectivity of tight junctions may depend upon the region of the
blood-retinal barrier. Such variation is further evidenced by studies suggesting that the
properties of RPE differ depending upon the region of the eye examined (77,78).

The properties of hfRPE are consistent with the claudin composition described here.
Claudin 19 was revealed as the predominant claudin in hfRPE. In a model of claudin 19
expression using the LLC-PK1 kidney cell line, claudin 19 was shown to cause decreased
Cl- diffusion across the tight junctional barrier (79). This could help contribute to the
relatively high TER we see in this hfRPE model. Also, the absorption of fluid from the
subretinal space is facilitated by the active transport of Cl- in the apical-to-basal direction;
with this apical-to-basal transport of Cl-, fluid follows out of the subretinal space through
osmosis. The maintenance of this flow of fluid out of the subretinal space is key to proper
visual function as extra fluid, or edema, in the subretinal space can result in distorted
transmission of images to the retina. Claudin 19 retarding undesired basal-to-apical
chloride flow would facilitate this aim. Furthermore, claudin 19 shows greater
permeability for cations than anions. This property is also consistent with maintenance of
visual function. Electrical potential across the outer blood-retinal barrier is subretinally,
or apically, positive; this positive charge is derived from the action of polarized pumps
and channels. The active secretion of Na+ by the Na+,K- ATPase in the RPE into the
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subretinal space is important for the maintenance of the apically positive charge (5). This
apically positive potential helps maintain a proper subretinal environment by facilitating
the absorption of Cl- and water from this area using Na+ coporters and antiporters. All
these mechanisms work together to maintain a healthy subretinal environment. In this
model, we observe claudin 19 to have a greater conductance for potassium than sodium.
Experiments are currently underway in our lab to investigate this phenomenon further.
This effect was altered by the presence or absence of serum but, as yet, the significance
of this to function remains to be investigated. Additionally, this study was limited in the
measurements of ion permeability. RPE is responsible for sodium, potassium, and
chloride gradients; however, the “sticky pore” problem leads to the need for estimation of
permeability with dilution and bi-ionic potentials (80,81).

Earlier work from our lab has suggested apical-to-basal fluid-phase transcytosis in hfRPE
(71), which would augment the Cl- mechanism for fluid transport described above.
Estimation of organic tracer, specifically mPEG, permeation here further supports that
evidence. The mechanisms used by organic tracers to transverse tight junctions can differ
from the pathways ions use (12,74,82-85). Smaller organic tracers with a radius of 4 Å or
less are able to transverse tight junctions through pores. However, molecules larger than
this must wait for tight junction strands to break and reseal. We used a solution of mPEG
containing mPEG350 and mPEG550 to investigate the apparent permeation of organic
tracers since these solutes are smaller and larger than 4 Å, respectively. The determined
apparent permeation coefficient of mPEG was greater in the apical-to-basal direction than
the basal-to-apical direction, signaling a mechanism of transcytosis in the apical-to-basal
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direction as mentioned above. We can estimate this rate of transcytosis at approximately
~2 µl/cm2/hr in serum-free medium, which is less than the total absorption of water for
hfRPE in vitro, estimated at ~10 µl/cm2/hr (52). Thus, the presence of such a gradient
appears consistent with the role of RPE.

Both culture models grown in growth medium and serum-free medium exhibited similar
functional characteristics and claudin/occludin expression. The results of this study did
not point to one medium over the other as a more ideal representation of native hfRPE.
Cells cultured in serum-free medium exhibited a TER closer to physiologic TER, which
supports the use of this medium. These cells showed changes in permeability resulting in
Na+ conductance increasing more than K+ conductance. These functional changes could
be explained by the increased expression of claudin 2 and claudin 10b seen via
immunofluorescence (versus cells cultured in growth medium). We attempted to further
study this phenomenon by performing siRNA knockdown of claudin 2 and claudin 10 in
serum-free medium cultured cells. Unfortunately, the transfection efficiency was low and
we were unable to achieve significant mRNA knockdown of either of these genes. The
use of serum-free medium is potentially beneficial in that this medium would eliminate
the variabilities associated with serum. Serum-free culture models would also facilitate
future studies involving stem cells, which require media without serum. In support of the
use of growth medium, this medium was used here to establish quiescent monolayers of
hfRPE with appreciable TER. Also, mRNA expression of certain claudins (specifically,
claudins 2, 10, 12, and 16) in cultured hfRPE was closer to native tissue levels in growth
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medium than in serum-free medium. Thus, it is difficult to designate either serum-free
medium or growth medium as ‘more ideal’ than the other.

Human RPE is likely a better model for human ocular disease than the RPE of other
species as the composition of RPE appears to differ between animals. Prior work shows
that in chickens claudin 20 is the major claudin, while also expressing claudin 1, claudin
4L2, claudin 5, claudin 2, claudin 11, and claudin 12; in chicken, claudin 19 is not
expressed. This strongly contrasts to the finding that claudin 19 is the predominant
claudin in hfRPE. Claudin 19 is also not detected by immunofluorescence in mouse RPE
but ZO-1 and occludin are expressed (N. Iwamoto and M. Furuse, Kobe University
Graduate School of Medicine, Japan, personal communication and our lab’s unpublished
data). This claudin is, however, exhibited in mouse kidney with the antibody used in this
study. In rats, claudin 1 is the only claudin found (V. Bonilha, Cleveland Clinic, personal
communication). Because of these differences in tight junction composition, the
properties of the outer blood-retinal barrier may differ between species. Importantly, the
contents of the subretinal space are determined by transcellular as well as paracellular
pathways (86-88). Further study to elucidate the properties of tight junctions and their
relation to subretinal space regulation is necessary before determining the appropriateness
of any of these animal models for the modeling of human disease.

Claudin 19 is not only the predominant claudin but also appears essential for the
formation of functional tight junctions. Following claudin 19 knockdown with siRNA,
the TER of the monolayer dramatically decreased to approximately 20 Ω×cm2, although
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cells displayed normal-appearing morphology. Despite the very low TER levels, actin,
occludin, ZO-1, and the other claudins all localized to the apical tight junctional complex.
This agrees with studies of embryonic chicken RPE which show the tight junction
proteins actin, occludin, ZO-1, and claudins localized to the apical tight junctions while
still showing discontinuities in tight junction strands by electron microscopy (89,90).
When these cells were subsequently maintained in retinal conditioned medium, they lost
these tight junction discontinuities and showed increased TER and decreased
permeability. The human ARPE19 RPE cell line also shows occludin and ZO-1
localizing to tight junctions, but, as discussed above, this cell line has rudimentary tight
junctions (27,34). This lack of adequate tight junction could be attributable to ARPE19’s
lack of claudin 19 expression (Gene Expression Omnibus, National Center for
Biotechnology Information, Accession No: GSE18811) (91).

The expression of other claudins following knockdown did not significantly change and
their expression levels were not sufficient to allow for tight junction function. Claudin 3
shows the next highest expression level following claudin 19; these results support that
this claudin is not capable of forming functional tight junctions without claudin 19
present. Furthermore, knockdown of claudin 3 with siRNA resulted in no apparent
change in tight junction function or morphology suggesting this protein does not play a
major role in hfRPE tight junctions. These results may help explain the severe ocular
problems experienced by patients with mutations in claudin 19 (18). Furthermore, this
functional disruption in tight junctions remained stable three weeks post-transfection.
This is similar to hfRPE following their initial plating, when tight junctions soon appear
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intact but do not exhibit stable tight junction function until 5-6 weeks after plating
(35,36,71,69).

Other models of RPE have shown dimerization between claudin 19 and other claudins; in
the distal tubules of the kidney, claudin 19 and claudin 16 must work together to make
their way into tight junctions (79). Without this interaction in the distal tubules, tight
junctions were non-functional. This example illustrates the importance of claudin-claudin
interactions in other epithelia; such interactions may be at play in hfRPE but have not
been elucidated by this study. Since claudin 16 is not present in hfRPE, a protein other
than claudin 16 may be needed to stabilize claudin 19 or transport it to the tight junction.

In modeling neovascular AMD using ectopic serum in this model, apical, or subretinal,
serum increased the TER of the monolayer. The cells showed decreased tight junction
permeability with a larger effect on K+ conductance versus Na+ conductance. The
increase in TER appears to be majorly derived from tight junction alterations because
conductance was measured while transcellular transport was inhibited by various
inhibitors (as described in the Introduction). Apically placed serum resulted in a
monolayer without apparent fluid phase transcytosis. In contrast, basally placed serum
transcytosis was estimated at approximately 4 µl/cm2/hr in the apical-to-basal direction.
The lack of transcytosis with subretinal serum could potentially contribute to the
collection of edema in the subretinal space during disease.
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The changes in these functional properties were accompanied by a significant increase in
occludin protein expression. The protein expression of claudin 3 also increased to a far
lesser degree. The mRNA expression of the claudins or occludin remained unchanged
following this intervention, suggesting that regulation following subretinal serum
exposure is only at the protein level. The data point to a potential major role of occludin
protein in mediating these changes; this would be consistent with occludin’s properties of
a short half-life and rapid association/dissociation rate constants (8,23,84,92).

The increased TER seen with subretinal serum in this model may show a mechanism
which hinders the gross lateral spread of disease in AMD patients. The tightened tight
junctions in one area of the outer blood-retinal barrier could stimulate the tightening of
junctions in neighboring cells, thus limiting edema. The effect is different from that seen
in lower vertebrates. In a chick model of RPE, subretinal serum resulted in a reduced
TER. This cross-species difference may be the result of divergent evolution under
different pressures. For example, chickens may not experience any disease such as AMD
and, hence, did not have to develop adaptations to fight subretinal edema.

Investigating the potential effects of proinflammatory cytokines on this outer bloodretinal barrier model reveals that these cytokines may help perpetuate diseases with an
inflammatory component, such as AMD. The three cytokines tested have differing effects
on the RPE, but exposure to TNF-α consistently led to leakier tight junctions. The
heterogeneous response of the monolayer to these cytokines perhaps reflects regional
variation in their effects.
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Of the cytokines tested here, TNF-α demonstrated the most profound effects on hfRPE.
Addition of TNF-α to the monolayer consistently led to dramatically decreased TER.
Additionally, TNF-α exposure led to changes in cell morphology with tight junctions
becoming more tortuous. This distorted tight junctional morphology could be detrimental
to function by increasing tight junction length and resulting in lower TER. Additionally,
apical stress fibers were apparent. Apical stress fibers are composed of actin filaments;
they connect tight and adherens junctions on one side of a cell to the apical junctional
complex on the opposite end of the cell. As discussed in the Introduction, apical stress
fibers have been witnessed in healing RPE. Despite these changes, no gaps between cells
were visualized in the hfRPE monolayer.

The changes seen with TNF-α exposure were accompanied by changes in tight junction
proteins. In growth medium, TNF-α exposure resulted in decreased levels of claudin 19,
claudin 3, and occludin protein levels as well as increased levels of claudin 2 protein.
Considering claudin 19’s important role in the formation of functional tight junctions in
hfRPE, this reduction may be largely responsible for the functional changes seen.
Although the decrease in claudin 19 protein levels was marked, it was less dramatic than
that seen with siRNA knockdown. Perhaps accordingly, the TER in TNF-α exposed cells
was higher than that seen following siRNA transfection. However, it is possible that the
level of claudin 19 protein present was high enough to form adequate tight junctions. In
that case, the reduction in TER could be the result of the reduction in claudin 3 or
occludin protein levels. The decrease in TER does not seem likely attributable to these
protein reductions as exposure with IL-1β and IFN-γ also decreased claudin 3 levels but
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without effects on TER. Furthermore, exposure to IFN-γ reduced occludin expression
without decreasing TER as substantially as TNF-α. Lastly, the decreased TER seen
following TNF-α exposure could be secondary to increased claudin 2 expression seen in
some cells; this would intuitively make sense as claudin 2 makes tight junctions more
permeable to cations leading to decreased TER. To test this hypothesis, we used claudin 2
siRNA to significantly reduce claudin 2 protein levels. Despite this decrease in claudin 2
protein levels, though, the TER of cells remained at a similar level to cells not exposed to
claudin 2 siRNA. Overall, this evidence points to the decreased expression of claudin 19
as the root of functional changes following TNF-α exposure.

In serum-free medium, TER, claudin 19, and occludin protein levels are all lower.
Following TNF-α exposure, TER further decreased. Examination of protein levels
showed a corresponding decrease in claudin 19, a slight increase in occludin, and no
change in claudin 3. The results in serum-free medium also point to decreased TER
following TNF-α exposure being attributable to claudin 19 reduction.

The effects of IL-1β and IFN-γ on hfRPE were not as consistent or dramatic as those of
TNF-α. The difference in functional effects from sample to sample may be secondary to
heterogeneity in effects of cytokines on the RPE monolayer. This is consistent with prior
studies, which show variations in the tight junction composition of secondary culture
models of hfRPE (71). However, although effects of cytokines on the RPE may be
regional, the functional measures used here, such as TER, are measurements of the entire
monolayer. For example, although we did see effects on functional measures and
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claudin/occludin expression following exposure to IL-1β and IFN-γ, immunofluorescence
showed that only certain cells were altered. Also, the effects of all cytokines were at the
protein level and not at the mRNA level. It remains possible that these protein effects
were the result of changes in other tight junction genes and/or proteins.

Prior work has shown consistent effects of IL-1β on tight junctions and the expression of
claudin 1 in the human RPE cell line ARPE19. We did see increased claudin 1 expression
in some cells of our model. We did not observe other changes in tight junction proteins.
In comparing our current work on hfRPE to results on ARPE19, we should remember
that the tight junctions of ARPE19 cells do not appear well-developed (27,34). Therefore,
comparisons between these two models may be limited.

There are several immediate limitations to this study. Both in testing culture conditions
and in modeling neovascular AMD with ectopic serum, we used bovine serum. As with
any serum, there are variabilities within different samples. To minimize such variations,
we used one single lot of bovine serum for all our experiments. Following this logic,
repeating these experiments with a different lot of serum may yield slightly different
results. However, the results presented here are based on multiple different hfRPE
samples and it seems unlikely that the variation within serum alone would be enough to
alter the results significantly. Furthermore, this study suggests serum-free medium is able
to produce a monolayer that serves as an adequate model of the outer blood-retinal
barrier. Use of this serum-free model would eliminate serum-to-serum variabilities in
culture medium. It would also be appropriate to extend these studies using human serum
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and whole blood to further examine effects of bleeding in neovascular AMD on the outer
blood-retinal barrier.

Another limitation of the study is that this model likely does not accurately reflect
regional variations in RPE. When the RPE is harvested, all best efforts are made to
dissect all the RPE without contamination of other eye tissue. Contamination is very low.
However, 100% yield of RPE is not possible and different regions of the RPE may be
unequally harvested from preparation to preparation. If there were regional variation in
RPE, some subpopulations of hfRPE may better survive in culture, further skewing the
model. These possible variations between different hfRPE secondary cultures may be the
root of the differing effects of cytokines from sample to sample, especially IFN-γ.
Exposure to TNF-α may have led to consistent effects because this cytokine had affected
all RPE subtypes. Notably, the functional measures used here, including TER and ion
selectivity, are reflective of the entire monolayer and not certain regions of the model.
Hence, effects of serum or cytokines that occur on a cell subpopulation level (as seen by
immunofluorescence) would not be evidenced by these functional measures.

This study suggests human fetal RPE is an appropriate model of the outer blood-retinal
barrier and can be used to examine ocular diseases, including AMD. Both serumcontaining and serum-free medium cultures appear to approximate the function and
composition of native hfRPE. In all cultures, claudin 19 is the predominant claudin and
its presence is necessary for the formation of functional tight junctions. Subretinal serum,
as might be seen in neovascular AMD, results in tightened tight junctions, a mechanism
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by which the gross lateral spread of edema may be limited in disease; this change appears
to be mediated by claudin protein levels. Exposure to proinflammatory cytokines,
particularly TNF-α, makes tight junctions leakier and may help perpetuate AMD and
other diseases with an inflammatory component. In the future, further investigation of
claudin 19 and its potential interactions with other tight junction proteins would be
warranted. Exogenous gene expression could be used to express minor claudins and/or
other tight junction proteins to examine potential interactions between claudin 19 and the
respective protein. Occludin’s potential role in regulating the subretinal space should also
be further investigated, perhaps using siRNA knockdown of occludin and the subsequent
response to subretinal serum. A stable TER after such an intervention would implicate
occludin as the mediator in this phenomenon of increased tight junction resistance. Also,
future studies modeling neovascular AMD should utilize human serum, preferably from
different subjects. Human whole blood should also be used since it is whole blood that is
present in choroidal neovascularization. These and other studies will hopefully help
further elucidate the pathogenesis behind AMD, one of the most visually devastating
diseases we face.
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